Categories: News

Dr. Sanaz Cordes Named Chief Executive Officer Of DotCom Therapy

MADISON, Wis., April 4, 2019 /PRNewswire/ — DotCom Therapy, Inc., an industry leader in teletherapy for speech, occupational, and behavioral health services, today announced the appointment Dr. Sanaz Cordes as its new chief executive officer.

Dr. Cordes brings more than 16 years of health and health tech experience to DotCom Therapy, along with a proven track record of growing sales and revenue. 

“I’m honored and excited to join this female-founded digital health company,” said Cordes, a known advocate for female entrepreneurs in the venture-backed health tech space. “My focus as CEO is to grow the company and expand our teletherapy services to schools, provider groups, and health systems.”

Prior to joining DotCom Therapy, Dr. Cordes was the founder and principal at Value Prop Shop, a consulting firm focused exclusively on working with health tech startups to strategically scale and grow revenue. She also served as the chief operations officer at healthfinch, a Madison-based tech startup, overseeing sales, marketing and internal operations. Previous roles also include chief development officer at Cogent Health in Nashville and director of strategic partnerships at Zynx Health in Los Angeles. Dr. Cordes began her career as a pediatrician and medical director for Providence Health and Services and holds an MD from UT Southwestern Medical School.

Rachel Robinson, founder and president of DotCom Therapy added, “Sanaz’s varied expertise is unparalleled. Her proven dedication to improving quality and access to healthcare aligns perfectly with our company mission, and we are so grateful to have her a part of our team.”

Since its inception in 2015, DotCom Therapy has experienced rapid market expansion with more than 115 company-employed therapists providing teletherapy to students and patients across 25 states and six countries. The funding from HealthX Ventures will support further development of DotCom Therapy’s technology, the addition of new teletherapy services and continued market expansion. 

“DotCom Therapy increases access to high quality therapy for people, regardless of location, while reducing the cost of care,” says Mark Bakken, managing partner at HealthX Ventures. “Sanaz’s leadership in scaling healthcare technology companies and her knowledge as a physician make her uniquely qualified to lead DotCom Therapy into the future.”

DotCom Therapy is the recipient of several awards including Entrepreneur 360 Best Companies and the Wisconsin Innovation Award. Through collaboration with leaders in the education and healthcare space, DotCom Therapy continues to create solutions that improve the quality and experience of teletherapy services.

About DotCom Therapy
Founded in 2015, DotCom Therapy is the leading teletherapy provider offering unparalleled speech, occupational, and behavioral therapy services via a face-to-face, online platform. DotCom Therapy’s outstanding team of therapists, combined with an intuitive platform, provide an exceptional user experience for their clients. The company is committed to making high quality therapy available to everyone, everywhere. Learn more at www.dotcomtherapy.com

About HealthX Ventures
HealthX Ventures is a digital healthcare-focused venture capital fund based in Madison, Wisconsin. HealthX supports early stage, high-growth companies who are making healthcare safer, more efficient, and more affordable by delivering easy-to-use, cost-effective, and scalable solutions to the market.

 

                                                             

View original content to download multimedia:http://www.prnewswire.com/news-releases/dr-sanaz-cordes-named-chief-executive-officer-of-dotcom-therapy-300824436.html

SOURCE DotCom Therapy

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

5 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

8 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

8 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

8 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

8 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

8 hours ago